US Patent 10526345 Compounds as GPR119 agonists
Patent 10526345 was granted and assigned to Mankind Pharma Ltd on January, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 11 Dec, 2023
Golden AI
Edits made to:
Article (+183 characters)
Article
Patent abstract
The present invention relates to novel compounds of formula (I) as GPR119 agonist, composition compositions containing such compounds and method of preparation thereof.
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105263450
Date of Patent
January 7, 2020
0Patent Application Number
154788830
Date Filed
April 4, 2017
0Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105263450
Date of Patent
January 7, 2020
0Patent Application Number
154788830
Date Filed
April 4, 2017
0Patent Primary Examiner
Edits on 31 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10526345 Compounds as GPR119 agonists
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10526345
Date of patent
January 7, 2020
Patent application number
15478883
Date Filed
April 4, 2017
Patent primary examiner
Find more entities like US Patent 10526345 Compounds as GPR119 agonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.